Gline Matthew

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 45% 68% 82%
Transactions
7 14% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 44%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Gline Matthew's trades of Roivant Sciences Ltd's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-20 2026-04-16
S Sale
36,651 +39.8%
33.29
US$2,160,931 		36,651 +39.8% 33.29 US$2,160,931
2026-04-16 2026-04-16
PrS Proposed sale
2,327
264.67
US$2,936,296 		2,327 264.67 US$2,936,296
2026-04-16 2026-04-16
PrS Proposed sale
2,599
146.17
US$1,983,518 		2,599 146.17 US$1,983,518
2025-12-17 2025-12-15
S Sale
943,527 -4.8%
21.68
US$20,455,665 		943,527 -4.8% 21.68 US$20,455,665
2025-12-17 2025-12-15
S Sale
566,116 -3.0%
21.68
US$12,273,395 		566,116 -3.0% 21.68 US$12,273,395
2025-12-17 2025-12-15
S Sale
230,357 -1.3%
21.68
US$4,994,140 		230,357 -1.3% 21.68 US$4,994,140
2025-12-15 2025-12-15
PrS Proposed sale
1,740,000
21.68
US$37,723,200 		1,740,000 21.68 US$37,723,200
2025-12-15 2025-12-15
PrS Proposed sale
1,740,000
21.68
US$37,723,200 		1,740,000 21.68 US$37,723,200
2025-09-18 2025-09-18
B Purchase
3,315 +0.0%
15.07
US$49,957 		3,315 +0.0% 15.07 US$49,957
2024-09-24 2024-09-23
S Sale
1,983,257 -10.0%
11.79
US$23,382,600 		1,983,257 -10.0% 11.79 US$23,382,600
2024-09-23 2024-09-23
PrS Proposed sale
1,983,257
11.79
US$23,383,088 		1,983,257 11.79 US$23,383,088
2023-11-21 2023-11-21
PrS Proposed sale
19,792
8.80
US$174,170 		19,792 8.80 US$174,170
2023-10-23 2023-10-23
PrS Proposed sale
19,792
9.66
US$191,191 		19,792 9.66 US$191,191
2023-09-28 2023-09-28
PrS Proposed sale
10,243
13.19
US$135,105 		10,243 13.19 US$135,105
2023-09-21 2023-09-21
PrS Proposed sale
19,792
10.33
US$204,451 		19,792 10.33 US$204,451
2023-08-28 2023-08-28
PrS Proposed sale
12,088
11.14
US$134,660 		12,088 11.14 US$134,660
2023-08-21 2023-08-21
PrS Proposed sale
19,792
10.87
US$215,139 		19,792 10.87 US$215,139
2023-07-28 2023-07-28
PrS Proposed sale
23,149
10.80
US$250,009 		23,149 10.80 US$250,009
2023-07-21 2023-07-21
PrS Proposed sale
19,792
11.13
US$220,285 		19,792 11.13 US$220,285
2023-06-21 2023-06-21
PrS Proposed sale
19,792
9.79
US$193,764 		19,792 9.79 US$193,764
2023-05-30 2023-05-30
PrS Proposed sale
53,281
9.31
US$496,046 		53,281 9.31 US$496,046
2023-05-22 2023-05-22
PrS Proposed sale
35,032
9.32
US$326,498 		35,032 9.32 US$326,498
2022-10-27 2022-10-25
PlS Planned sale
19,276 -1.6%
4.40
US$84,814 		19,276 -1.6% 4.40 US$84,814
2022-09-27 2022-09-23
PlS Planned sale
21,053 -1.7%
3.07
US$64,633 		21,053 -1.7% 3.07 US$64,633
2022-08-26 2022-08-24
PlS Planned sale
20,009 -1.6%
3.71
US$74,233 		20,009 -1.6% 3.71 US$74,233
2022-07-27 2022-07-25
PlS Planned sale
20,455 -1.6%
4.33
US$88,570 		20,455 -1.6% 4.33 US$88,570
2022-06-27 2022-06-23
PlS Planned sale
19,855 -1.6%
4.34
US$86,171 		19,855 -1.6% 4.34 US$86,171
2022-05-24 2022-05-20
S Sale
139,791 -10.0%
3.70
US$517,227 		139,791 -10.0% 3.70 US$517,227
2022-04-27 2022-04-25
PlS Planned sale
8,509 -0.6%
3.84
US$32,675 		8,509 -0.6% 3.84 US$32,675
2022-04-01 2022-03-30
PlS Planned sale
33,686 -2.3%
4.84
US$163,040 		33,686 -2.3% 4.84 US$163,040
2022-03-29 2022-03-25
PlS Planned sale
35,386 -2.3%
5.06
US$179,053 		35,386 -2.3% 5.06 US$179,053
2022-03-22 2022-03-18
PlS Planned sale
82,006 -5.2%
5.13
US$420,691 		82,006 -5.2% 5.13 US$420,691
2022-03-09 2022-03-07
PlS Planned sale
92,324 -5.5%
5.52
US$509,628 		92,324 -5.5% 5.52 US$509,628